AML is the most common form of adult acute leukemia
, accounting for 80% of all diagnosed cases, with approximately 13,000 new cases diagnosed in the U.
NEW YORK -- Bioenvision (Nasdaq: BIVN) today announced interim results from the ongoing clinical studies of clofarabine in pediatric and adult acute leukemia
trials which confirm clofarabine's outstanding profile observed in previous studies.
NEW YORK -- Bioenvision (Nasdaq: BIVN) announced today that an update of clinical data from continuing trials of clofarabine in pediatric and adult acute leukemia
will be presented at the 6th International Symposium and Expert Workshop on Leukemia and Lymphoma in Amsterdam on March 17th-19th.
Anderson), Houston, reported the latest data from ongoing pediatric and adult acute leukemia
Amex:BIV) today announced that it has extended its exclusive, irrevocable option, subject to certain conditions, to manufacture, market and distribute clofarabine, Bioenvision's lead drug for the treatment of pediatric and adult acute leukemias
, in Japan and South East Asia.